Video

Dr. Stevenson on the Importance of Early Screening in Lung Cancer

James Stevenson, MD, discusses the importance of early screening in lung cancer.

James Stevenson, MD, medical oncologist and hematologist, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the importance of early screening in lung cancer. 

Chest CT screening for lung cancer is an easy strategy to detect potentially cancerous nodules, Stevenson says. Being able to detect potentially cancerous nodules is the goal of any type of cancer screening that is completed in the early-stage setting when patients may be asymptomatic, Stevenson explains.

Additional data are likely to emerge regarding larger screening programs, which will reveal the percentage of small cell lung cancer vs non–small cell lung cancer vs other cancer types that are detected through screening. Moreover, data may indicate whether screening can lead to a stage migration in lung cancer where a higher percentage of patients are being diagnosed at earlier stages, Stevenson concludes.

Related Videos
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss unmet needs and future research directions in ALK-positive and ROS1-positive NSCLC.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for lorlatinib in ROS1-positive NSCLC after crizotinib and chemotherapy.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for taletrectinib in ROS1-positive advanced non–small cell lung cancer.
Binod Dhakal, MD
Sheldon M. Feldman, MD
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, on progression patterns and subsequent therapies after lorlatinib in ALK-positive NSCLC.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss preclinical CNS data for the ROS1 inhibitor zidesamtinib.